82 related articles for article (PubMed ID: 12596519)
1. [Protective effect of adenosine receptor agonists in a model of spinal cord injury in rats].
Sufianova GZ; Usov LA; Sufianov AA; Perelomov IuP; Raevskaia LIu; Shapkin AG
Eksp Klin Farmakol; 2002; 65(5):58-61. PubMed ID: 12596519
[TBL] [Abstract][Full Text] [Related]
2. [Protective effect of A-agonists in a minimum invasive model of spinal cord ischemia in rats].
Sufianova GZ; Usov LA; Sufianov AA; Shapkin AG; Raevskaia LIu; Golubev SS
Eksp Klin Farmakol; 2003; 66(1):23-6. PubMed ID: 12683076
[TBL] [Abstract][Full Text] [Related]
3. [Protective effect of cyclopentyladenosine in a minimally invasive model of acute cerebral focal ischemia in rats].
Sufianova GZ; Usov LA; Sufianov AA; Shapkin AG; Raevskaia LIu
Eksp Klin Farmakol; 2002; 65(1):24-6. PubMed ID: 12025778
[TBL] [Abstract][Full Text] [Related]
4. [Comparative characteristics of A1-receptor agonists as neuroprotective agents].
Kulinskiĭ VI; Minakina LN; Usov LA
Eksp Klin Farmakol; 2001; 64(5):19-22. PubMed ID: 11764492
[TBL] [Abstract][Full Text] [Related]
5. Intraspinal injection of adenosine agonists protect against L-NAME induced neuronal loss in the rat.
Dora CD; Koch S; Sanchez A; Ruenes G; Liu S; Yezierski RP
J Neurotrauma; 1998 Jul; 15(7):473-83. PubMed ID: 9674551
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of wind-up by the combined administration of adenosine A1 receptor ligands on spinalized rats with carrageenan-induced inflammation.
Ramos-Zepeda G; Herrero JF
Neurosci Lett; 2005 Aug 12-19; 384(1-2):177-82. PubMed ID: 15893424
[TBL] [Abstract][Full Text] [Related]
7. The antinociceptive effects of the systemic adenosine A1 receptor agonist CPA in the absence and in the presence of spinal cord sensitization.
Curros-Criado MM; Herrero JF
Pharmacol Biochem Behav; 2005 Dec; 82(4):721-6. PubMed ID: 16403570
[TBL] [Abstract][Full Text] [Related]
8. 8-Alkylamino-substituted analogs of N6-cyclopentyladenosine are partial agonists for the cardiovascular adenosine A1 receptors in vivo.
Van Schaick EA; Math-ot RA; Gubbens-Stibbe JM; Langemeijer MW; Roelen HC; Ijzerman AP; Danhof M
J Pharmacol Exp Ther; 1997 Nov; 283(2):800-8. PubMed ID: 9353401
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning.
Joosen MJ; Bueters TJ; van Helden HP
Arch Toxicol; 2004 Jan; 78(1):34-9. PubMed ID: 14508639
[TBL] [Abstract][Full Text] [Related]
10. [Adenosine in treatment of rats with spinal cord injury].
Zhang Q; Zhao J; Wang Q; Li M; Hou T; Li Z; Zhang L
Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):219-22. PubMed ID: 11832034
[TBL] [Abstract][Full Text] [Related]
11. Negative chronotropic response to adenosine receptor stimulation in rat right atria after run training.
Priviero F; De Nucci G; Antunes E; Zanesco A
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):741-3. PubMed ID: 15554918
[TBL] [Abstract][Full Text] [Related]
12. Recovery of respiratory function following C2 hemi and carotid body denervation in adult rats: influence of peripheral adenosine receptors.
Bae H; Nantwi KD; Goshgarian HG
Exp Neurol; 2005 Jan; 191(1):94-103. PubMed ID: 15589516
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of infliximab in experimental spinal cord injury.
Kurt G; Ergün E; Cemil B; Börcek AO; Börcek P; Gülbahar O; Ceviker N
Surg Neurol; 2009 Mar; 71(3):332-6, discussion 336. PubMed ID: 18440605
[TBL] [Abstract][Full Text] [Related]
14. Influence of adenosine agonists and antiepileptic drugs on theophylline-induced seizures in rats.
Gupta YK; Malhotra J
Indian J Physiol Pharmacol; 1998 Oct; 42(4):491-7. PubMed ID: 10874349
[TBL] [Abstract][Full Text] [Related]
15. Increase in adenosine A1 receptor gene expression in the liver of streptozotocin-induced diabetic rats.
Liu IM; Tzeng TF; Tsai CC; Lai TY; Chang CT; Cheng JT
Diabetes Metab Res Rev; 2003; 19(3):209-15. PubMed ID: 12789654
[TBL] [Abstract][Full Text] [Related]
16. N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.
Knutsen LJ; Lau J; Petersen H; Thomsen C; Weis JU; Shalmi M; Judge ME; Hansen AJ; Sheardown MJ
J Med Chem; 1999 Sep; 42(18):3463-77. PubMed ID: 10479279
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin.
Bueters TJ; Joosen MJ; van Helden HP; Ijzerman AP; Danhof M
J Pharmacol Exp Ther; 2003 Mar; 304(3):1307-13. PubMed ID: 12604711
[TBL] [Abstract][Full Text] [Related]
18. The role of intraspinal adenosine A1 receptors in sympathetic regulation.
Peng SC; Ho CM; Ho ST; Tsai SK; Su CK
Eur J Pharmacol; 2004 May; 492(1):49-55. PubMed ID: 15145705
[TBL] [Abstract][Full Text] [Related]
19. Time-level relationship for nitric oxide and the protective effects of aminoguanidine in experimental spinal cord injury.
Soy O; Aslan O; Uzun H; Barut S; Iğdem AA; Belce A; Colak A
Acta Neurochir (Wien); 2004 Dec; 146(12):1329-35; discussion 1335-6. PubMed ID: 15309585
[TBL] [Abstract][Full Text] [Related]
20. Spinal vs. supraspinal antinociceptive activity of the adenosine A(1) receptor agonist cyclopentyl-adenosine in rats with inflammation.
Ramos-Zepeda G; Schröder W; Rosenow S; Herrero JF
Eur J Pharmacol; 2004 Sep; 499(3):247-56. PubMed ID: 15381046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
